SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042709
Filing Date
2021-08-09
Accepted
2021-08-09 16:46:32
Documents
87
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20210630.htm   iXBRL 10-Q 2769421
2 EX-3.1 epzm-ex31_73.htm EX-3.1 70440
3 EX-31.1 epzm-ex311_10.htm EX-31.1 8520
4 EX-31.2 epzm-ex312_9.htm EX-31.2 8659
5 EX-32.1 epzm-ex321_8.htm EX-32.1 6230
  Complete submission text file 0001564590-21-042709.txt   10762884

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20210630.xsd EX-101.SCH 80098
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20210630_cal.xml EX-101.CAL 59652
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20210630_def.xml EX-101.DEF 272862
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20210630_lab.xml EX-101.LAB 579506
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20210630_pre.xml EX-101.PRE 448169
11 EXTRACTED XBRL INSTANCE DOCUMENT epzm-10q_20210630_htm.xml XML 2107475
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 211157154
SIC: 2834 Pharmaceutical Preparations